中文产业新闻评分68Chinese source
伏美替尼FURVENT全球三期试验一线治疗EGFR exon20ins非小细胞肺癌未达主要终点
伏美替尼全球三期临床失败
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
伏美替尼全球三期临床失败
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.